Skip to Content

Riluzole Pregnancy and Breastfeeding Warnings

Riluzole is also known as: Rilutek

Riluzole Pregnancy Warnings

Riluzole has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryotoxicity. There are no controlled data in human pregnancy. Riluzole should only be given during pregnancy when benefit outweighs risk.

Animal embryotoxicity has been observed at 2.6 and 11.5 times the recommended maximum human daily dose on a mg/m2 basis. Maternal toxicity was also noted at these doses. Decreased implantations, increased intrauterine death, decreased viability and decreased growth occurred in animal studies at 1.5 times the recommended daily dose on a mg/m2 basis. Impairment of fertility has been noted in animal studies in both the male and the female of the species at 1.5 times the recommended daily dose on a mg/m2 basis.

See references

Riluzole Breastfeeding Warnings

There are no data on the excretion of riluzole into human milk.

See references

References for pregnancy information

  1. "Product Information. Rilutek (riluzole)." Rhone-Poulenc Rorer, Collegeville, PA.

References for breastfeeding information

  1. "Product Information. Rilutek (riluzole)." Rhone-Poulenc Rorer, Collegeville, PA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.